AZT-P-ddI
AZT-P-ddI is an antiviral heterodimer composed of Zidovudine (AZT) and Didanosine (ddI) (HY-B0249). AZT-P-ddI shows inhibitory effect against HIV-1 with an EC50 of 0.14 nM. AZT-P-ddI can be used for the research of infection[1].
Product Specifications
CAS Number
121135-53-3
Product Name Alternative
IVX-E-59
UNSPSC
12352005
Target
HIV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C1C2=C(NC=N1)N([C@@H]3O[C@@H](CC3)COP(OC[C@@H]4[C@H](C[C@H](N5C(NC(C(C)=C5)=O)=O)O4)N=[N+]=[N-])(O)=O)C=N2
Molecular Formula
C20H24N9O9P
Molecular Weight
565.43
References & Citations
[1]Schinazi RF, et al. Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1990 Jun;34 (6) :1061-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400994-500 1x 500 µL
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400633-100 1x 100 µL
Von Willebrand Factor (3E2D10), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740043-500 1x 500 µL
P21 / WAF1 (WA-1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401073-500 1x 500 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940977-100 1x 100 µL
TGF-beta (1D11.16.8), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details